User profiles for Martina E. McMenamin
 | Martina McMenaminWHO Collaborating Centre for Infectious Disease Epidemiology and Control, The University … Verified email at hku.hk Cited by 381 |
Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study
Background Hong Kong maintained low circulation of SARS-CoV-2 until a major community
epidemic of the omicron (B.1.1.529) sublineage BA.2 began in January, 2022. Both mRNA (…
epidemic of the omicron (B.1.1.529) sublineage BA.2 began in January, 2022. Both mRNA (…
[HTML][HTML] Estimation of relative vaccine effectiveness in influenza: a systematic review of methodology
ME McMenamin, HS Bond, SG Sullivan… - Epidemiology, 2022 - journals.lww.com
Background: When new vaccine components or platforms are developed, they will typically
need to demonstrate noninferiority or superiority over existing products, resulting in the …
need to demonstrate noninferiority or superiority over existing products, resulting in the …
CoronaVac efficacy data from Turkey
ME McMenamin, BJ Cowling - The Lancet, 2021 - thelancet.com
… We thank Martina McMenamin and Benjamin Cowling for raising important issues on vaccine
trials in the context of our Article.The work they refer to by Palacios and colleagues2 has …
trials in the context of our Article.The work they refer to by Palacios and colleagues2 has …
[HTML][HTML] Reported effectiveness of COVID-19 monovalent booster vaccines and hybrid immunity against mild and severe Omicron disease in adults: A systematic …
Background Waning of COVID-19 vaccine efficacy/effectiveness (VE) has been observed
across settings and epidemiological contexts. We conducted a systematic review of COVID-19 …
across settings and epidemiological contexts. We conducted a systematic review of COVID-19 …
Sample size estimation using a latent variable model for mixed outcome co‐primary, multiple primary and composite endpoints
ME McMenamin, JK Barrett, A Berglind… - Statistics in …, 2022 - Wiley Online Library
Mixed outcome endpoints that combine multiple continuous and discrete components are
often employed as primary outcome measures in clinical trials. These may be in the form of co‐…
often employed as primary outcome measures in clinical trials. These may be in the form of co‐…
Martina E McMenamin
BJ Cowling, MD Tanriover, HL Doğanay, S Unal… - Lancet, 2021 - thelancet.com
… We thank Martina McMenamin and Benjamin Cowling for raising important issues on vaccine
trials in the context of our Article.The work they refer to by Palacios and colleagues2 has …
trials in the context of our Article.The work they refer to by Palacios and colleagues2 has …
Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong (preprint)
Background: Hong Kong maintained extremely low circulation of SARS-CoV-2 until a major
community epidemic of Omicron BA. 2 starting in January 2022. Both mRNA BNT162b2 (…
community epidemic of Omicron BA. 2 starting in January 2022. Both mRNA BNT162b2 (…
Reported Effectiveness of COVID-19 Booster Vaccines: A Systematic Review of Early Literature and Implications for Emerging Vaccination Policy
J Nealon, Y Mefsin, M McMenamin… - Available at SSRN …, 2022 - papers.ssrn.com
… Joshua Nealon PhD,1 Yonatan Mefsin PhD,1 Martina E. McMenamin PhD,1 Kylie EC Ainslie
5 … McMenamin ME, Bond HS, Sullivan SG, Cowling BJ. Estimation of Relative Vaccine 406 …
5 … McMenamin ME, Bond HS, Sullivan SG, Cowling BJ. Estimation of Relative Vaccine 406 …
CoronaVac efficacy data from Turkey–Authors' reply
MD Tanriover, HL Doğanay, S Unal, M Akova - The Lancet, 2021 - thelancet.com
… We thank Martina McMenamin and Benjamin Cowling for raising important issues on vaccine
trials in the context of our Article.The work they refer to by Palacios and colleagues2 has …
trials in the context of our Article.The work they refer to by Palacios and colleagues2 has …
WHO Global Situational Alert System: a mixed methods multistage approach to identify country-level COVID-19 alerts
M McMenamin, J Kolmer, I Djordjevic, F Campbell… - BMJ Global …, 2023 - gh.bmj.com
Background Globally, since 1 January 2020 and as of 24 January 2023, there have been
over 664 million cases of COVID-19 and over 6.7 million deaths reported to WHO. WHO …
over 664 million cases of COVID-19 and over 6.7 million deaths reported to WHO. WHO …
